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Abstract: Chorioamnionitis can lead to inflammation and injury of the liver and gut, thereby
predisposing patients to adverse outcomes such as necrotizing enterocolitis (NEC). In addition,
intestinal bile acids (BAs) accumulation is causally linked to NEC development. Plant sterols
are a promising intervention to prevent NEC development, considering their anti-inflammatory
properties in the liver. Therefore, we investigated whether an intra-amniotic (IA) Ureaplasma parvum
(UP) infection affected the liver and enterohepatic circulation (EHC) and evaluated whether an IA
administered plant sterol mixture dissolved in β-cyclodextrin exerted prophylactic effects. An ovine
chorioamnionitis model was used in which liver inflammation and the EHC were assessed following
IA UP exposure in the presence or absence of IA prophylactic plant sterols (a mixture of β-sitosterol
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and campesterol dissolved in β-cyclodextrin (carrier)) or carrier alone. IA UP exposure caused an
inflammatory reaction in the liver, histologically seen as clustered and conflated hepatic erythropoiesis
in the parenchyma, which was partially prevented by IA administration of sterol + β-cyclodextrin,
or β-cyclodextrin alone. In addition, IA administration of β-cyclodextrin prior to UP caused changes
in the expression of several hepatic BAs transporters, without causing alterations in other aspects of the
EHC. Thereby, the addition of plant sterols to the carrier β-cyclodextrin did not have additional effects.
Keywords: Ureaplasma parvum; intra-uterine infection; chorioamnionitis; preterm birth; plant sterols;
liver; enterohepatic circulation; sheep
1. Introduction
Preterm birth, birth before 37 weeks of gestation, is the leading cause of morbidity and mortality
among infants worldwide [1]. An important cause of preterm birth is chorioamnionitis, an inflammatory
cell infiltration of the fetal membranes, which is defined as an independent risk factor for the
development of necrotizing enterocolitis (NEC) [2–5]. The most common organism isolated from the
amniotic fluid of pregnant women with chorioamnionitis is Ureaplasma parvum (UP), a commensal of
the urogenital tract of humans [6–8]. UP colonization in preterm infants has been associated with an
increased incidence of NEC [2–5].
A strong interaction exists between the intestine and liver, wherein a crucial role is played by the
enterohepatic circulation (EHC) of bile acids (BAs). There is increasing attention towards the role of
BAs as critical regulators of intestinal epithelial function [9]. Within this context, their contribution
to NEC pathophysiology has recently been studied. In the week preceding NEC manifestation, fecal
unconjugated BA levels were found to be higher in preterm infants, eventually developing NEC
compared with gestation-matched controls [10]. More precisely, the intraluminal accumulation of
conjugated BAs resulted in intestinal epithelial damage, similar to the histopathological findings
in NEC [11]. These high concentrations of intraluminal BAs might be the result of increased BA
synthesis, as was shown in a rat NEC model [12]. In addition, the increased expression of the
apical sodium-dependent bile acid transporter (ASBT) in the terminal ileum, a protein involved
in the uptake of conjugated BAs into the enterocytes, was reported in preterm infants with NEC
and in an experimental NEC model with rodents which correlated with the location of intestinal
damage, suggesting increased BAs uptake by enterocytes [13,14]. Consequently, high concentrations
of intraluminal BAs resulted in their accumulation within enterocytes, with concomitant enterocyte
damage [10]. Moreover, a decreased expression of the ileal bile acid-binding protein (IBABP) was
seen in the terminal ileum of rats in an experimental NEC model, suggesting insufficient transport
from the apical to the basolateral side of enterocytes with consequent BAs accumulation within the
enterocytes [14]. The important role of the liver and the gut-liver axis in NEC pathogenesis is further
underlined by the presence of increased hepatic inflammation in neonatal rats with NEC, which
correlated with the progression of intestinal damage during disease development [15].
Interestingly, in a recent study, chorioamnionitis induced by six days of intra-uterine UP exposure
caused a reduced amount of conjugated BAs in the enterocytes of the terminal ileum of fetal sheep [16].
In addition, it was shown that fetuses exposed to endotoxin-induced chorioamnionitis develop hepatic
inflammation and a disturbed lipid metabolism in utero [17]. These findings prompted us to investigate
the liver and EHC alterations in a model of UP-induced chorioamnionitis in fetal sheep.
From a treatment perspective, plant sterols, which are dietary constituents present in vegetable
oils, nuts, grains, and fruit [18], seem promising due to their immune-modulatory properties [19–27].
Moreover, they have even shown to be anti-inflammatory in the liver of mice that developed
non-alcoholic fatty liver disease (NASH) [28]. We previously showed that fetal gut inflammation
and mucosal damage following IA UP exposure were prevented by prophylactic plant sterol
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supplementation in the amniotic fluid [16]. Therefore, the second aim of this study was to investigate
the effects of prophylactic IA administration of a plant sterol mixture dissolved in β-cyclodextrin as
carriers on liver inflammation and potential EHC alterations.
2. Materials and Methods
2.1. Animal Model and Experimental Procedures
The animal experiments were approved by the Animal Ethics Committee of the University of
Western Australia (Perth, Australia; ethical approval code: RA/3/100/1378). The animal model and
experimental procedures were previously described [16]. In short, fifty ewes with singleton fetuses
were randomly assigned to the six different study groups (Figure 1). After drop-outs, the group size for
data analyses was six to seven animals per group. One group of the date-mated pregnant ewes received
an IA ultrasound-guided injection of Ureaplasma parvum serovar 3 (strain HPA5, 107 color-changing
units [CCU]), six days prior to delivery. To evaluate the preventive effect of plant sterols, the amniotic
fluid in two experimental groups was enriched with a mixture of β-sitosterol (70%) and campesterol
(30%) (total of 0.6 mg/mL), dissolved in a carrier, 18% 2-hydroxypropyl-β-cyclodextrin (H107, Sigma
Aldrich, St. Louis, MO, USA) eleven days prior to delivery in combination with saline, or UP six days
prior to delivery. To assess the carrier effect separately from the plant sterols, in two groups, the carrier
was given alone with saline or carrier in combination with UP. A group receiving IA injections of saline
(eleven or six days prior to delivery) served as control (Figure 1).
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Figure 1. Experi ental design. Animals were randomly assigned to six different study groups;
control: n = 6, plant sterols in carrier: n = 6, carrier alone: n = 6, Ureaplasma parvum (UP): n = 7,
UP + plant sterols in carrier: n = 7, UP + Carrier alone: n = 7. Plant sterols dissolved in the carrier
(β-cyclodextrin) were administered by an intra-amniotic (IA) injection at 122d of gestational age ( ),
efore t e o set of c orioa io itis a ere re eate e er t o a s til 131 . e a i als
ere re t rel eli ere t . r s recei e t e c rrier l e ( it t e l t
st r ls) IA to assess the eff cts of the carrier separately from the plant sterols. Ureaplasma arvum serovar
3 (107 color-changing units [CCU]) was given by IA injection at 127d GA to induce chorioamnionitis.
T e c ntrol group received saline on all administrati time poi t .
= 150 days), the quivalent of 33– 4 weeks of human gestation. After cesarean section, fetuses
were euthaniz d directly w th intravenous pentobarbital (100 mg/kg, Valabarb, Jurox, Rutherford,
NSW, Australia). During necropsy, blood, liver, and terminal ileum samples were sampled.
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2.2. Qualitative Analysis of Liver Histology
H&E slides were scored on a zero to four scale for degree of hepatic sinusoidal dilatation, shape
and size of central veins, and number and location of extramedullary hematopoietic clusters by an
independent pathologist blinded to the experimental set-up. Zero represented no sinusoidal dilatation,
no divergent shape or size of central veins, and no inflammation. Four represented the other end
of the scale, namely pronounced sinusoidal dilatation throughout the parenchyma, large central
veins with venous stowing throughout the parenchyma, and a severely increased number of clusters
of hematopoiesis.
2.3. Total Bile Acid Assay
Total bile acids (tBAs) in plasma and liver homogenate were measured by an enzymatic cycling
method using the Total Bile Acids Assay kit, according to the manufacture protocol (Diazyme
Laboratories, Poway, CA, USA). tBAs in liver homogenate were corrected for protein content.
2.4. RNA Extraction and Real-Time PCR
RNA was isolated from snap-frozen liver and ileum tissue using TRI reagent (Thermo Fisher
Scientific, Waltham, MA, USA)/chloroform extraction. The RNA was reverse transcribed into cDNA
using a sensifast cDNA Synthesis kit (Bioline, London, UK). Quantitative real-time PCR (qPCR) was
executed with the selected primer in Sensimix SYBR & Fluorescein Kit (Bioline, London, UK). The qPCR
reactions were performed with the use of the LightCycler 480 Instrument (Roche Applied Science, Basel,
Switzerland) for 45 cycles. The gene expression levels of cholesterol 7 alpha-hydroxylase (CYP7A1),
Cytochrome P450 Family 27 Subfamily A Member 1 (CYP27A1), Na+-taurocholate cotransporting
polypeptide (NTCP), bile salt export pump (BSEP), apical sodium–dependent bile acid transporter
(ASBT), fibroblast growth factor 19 (FGF19), ileal bile acid-binding protein (IBABP) and organic solute
transporter alpha-beta (OSTα-β) were determined to assess changes in the EHC. LinRegPCR software
(version 2016.0, Heart Failure Research Center, Academic Medical Center, Amsterdam, the Netherlands)
was used to calculate the expression levels. As a normalization factor, the geometric mean of the
expression levels of three reference genes (ribosomal protein S15 (RPS15), glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and peptidylprolyl isomerase A (PPIA)) was calculated. The data were
expressed as a fold increase over the control value, arbitrary unit (AU). An overview of the used primer
sequences is shown in Table 1.
Table 1. Primer sequences.
Primer Forward Reverse
RPS15 5′-CGAGATGGTGGGCAGCAT-3′ 5′-GCTTGATTTCCACCTGGTTGA-3′
GAPDH 5′-GGAAGCTCACTGGCATGGC-3′ 5′-CCTGCTTCACCACCTTCTTG-3′
PPIA 5′-TTATAAAGGTTCCTGCTTTCACAGAA-3′ 5′-ATGGACTTGCCACCAGTACCA-3′
CYP7A1 5′-GGGCATCACAAGCAAACACC-3′ 5′-GATGATACTGTCTAGCACGGG-3′
CYP27A1 5′- CCCAAGAATACCCAGTTTGTGC-3′ 5′- GGTGGCAGAAGACTCAGTTCA-3′
NTCP 5′-TCCTCAAATCCAAACGGCCA-3′ 5′-GTTTGGATCGTCCATTGAGGC-3′
BSEP 5′-ACTCAGTAATTCTTCGCAGTGTG-3′ 5′-ATCGAAACAATCGAAAGAAGCCA-3′
ASBT 5′-CATGGACCTGAGCGTCAGCAT-3′ 5′-CACGGAGACGGGAACAACAA-3′
FGF19 5′-TTGATGGAGATCAGGGCGGT-3′ 5′-CGGATCTCCTCCTCGAAAGC-3′
IBABP 5′-ACAAGAAGTTCAAGGTCACCG-3′ 5′-TGATACGGCTTTATGGCCCC-3′
OSTα 5′-ATCCCAGGTACACGGCAGAT-3′ 5′-ATTGAGGCCAGGACAAGCAA-3′
OSTβ 5′-CCGAGTAGAGGATGCAACTCC-3′ 5′-TTTGTTTTTCCGGTGGCAGC-3′
2.5. Data Analysis
Statistical analyses were performed using GraphPad Prism (version 6.01, GraphPad Software
Inc., La Jolla, CA, USA). Data are presented as median with interquartile range (IQR). Differences in
Nutrients 2020, 12, 1312 5 of 11
the qualitative analysis of liver histology using scorings were assessed using the Kruskal–Wallis test
followed by Dunn’s post hoc test. A square root transformation was applied to the other data to obtain
a normal distribution. A comparison between different experimental groups was performed using
the two-way ANOVA followed by Tukey’s or Sidak’s multiple comparisons test. Differences were
considered statistically significant at p < 0.05.
3. Results
3.1. Sterol + Carrier, as Well as Carrier Alone, Partly Decrease Hepatic Inflammation Due to UP-Induced
Chorioamnionitis
Histologically, no signs of sinusoidal dilatation, divergent shape, or size of central veins or
inflammation were observed in the control group and animals exposed to the sterol + carrier or carrier
alone (Figure 2E–G). All animals exposed to UP (all groups) displayed pronounced sinusoidal dilation
throughout the entire liver parenchyma (all p < 0.01; Figure 2E) without dilatation of the central veins.
Administration of sterol + carrier or carrier alone prior to UP exposure did not decrease sinusoidal
dilation. However, the animals treated with sterol + carrier prior to UP displayed enlarged central
veins compared to control, sterol + carrier, UP, and UP + carrier (all p < 0.10; Figure 2F), without
shape divergence.
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Figure 2. H&E slides scored on a zero to four scale for degree of sinusoidal dilatation, shape and size
of central veins, and number and location of extramedullary hematopoietic clusters by an independent
pathologist. Representative images of the control (A), UP (B), UP + sterols dissolved in carrier (C) and
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UP + carrier alone (D). (E): Increased sinusoidal dilation in animals exposed to UP, UP + sterols
dissolved in the carrier, and UP + carrier alone. * p < 0.01, ** p < 001, *** p < 0.0005 compared to control.
(F): The UP + sterol dissolved in the carrier group displayed enlarged central veins, without shape
divergence. * p = 0.0002 compared to control. (G): Increased number of extramedullary hematopoietic
clusters in the animals exposed to UP. Treatment with prophylactic IA sterols dissolved in the carrier or
carrier alone prior to UP exposure tended to decrease the number of extramedullary hematopoietic
clusters. Specifically, the extramedullary hematopoiesis in all the animals exposed to UP is interpreted
as clustered and conflated hepatic erythropoiesis in the parenchyma, which are indicated by white
triangles. * p = 0.001 compared to control.
A significant increase in the number of erythropoietic clusters was observed in animals exposed to
UP (p < 0.005; Figure 2G), as the extramedullary hematopoiesis is interpreted as clustered and conflated
hepatic erythropoiesis in the parenchyma (Figure 2B–D). The administration of sterol + carrier or carrier
alone prior to UP exposure tended to have lower numbers of erythropoietic clusters (both p < 0.10;
Figure 2G), suggesting that the carrier exerted this anti-inflammatory effect while dissolving sterols in
the carrier did not have an additional effect on top of the carrier.
3.2. Administration of the Carrier Alone Prior to UP Exposure Causes Increased BSEP Expression in the Liver
NTCP and BSEP mRNA expression levels were not altered in animals exposed to UP alone,
compared to control (Figure 3A,B). However, in the UP + carrier group, an increased BSEP mRNA
expression was observed compared with UP alone or UP + sterol + carrier (p < 0.05; Figure 3B).
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Figure 3. Relative gene expression of Na+-taurocholate cotransporting polypeptide (NTCP) (A) and
bile salt export pump (BSEP) (B) in AU in the liver. (A): Increased NTCP gene expression in animals
exposed to UP + sterols dissolved in the carrier. (B): Increased BSEP gene expression in animals
exposed to UP + carrier alone.
No differences in the amount of tBAs in plas a or the liver were measured (Supplementary
Materials 1: Figure S1). Furthermore, no differences were observed in the mRNA expression of the
BAs synthesis markers CYP7A1 and CYP27A1 (Supplementary Materials 2: Figure S2). In addition, no
differences were observed in the mRNA expression of any of the BAs transporters in the gut (ASBT,
OSTα-β; Supplementary Materials 3: Figure S3), as well as intestinal FGF19 or IBABP (Supplementary
Materials 4: Figure S4).
A summary of all the results is given in the synthetic table (Table 2).
Nutrients 2020, 12, 1312 7 of 11
Table 2. Synthetic table.
Control Sterol + Carrier Carrier UP UP + Sterol + Carrier UP + Carrier
Hepatic sinusoidal
dilation nc nc nc ↑
↑ (Control & Sterol +
Carrier ↑
Shape and size of
central veins nc nc nc nc
↑ (Control, Sterol + Carrier,
UP & UP + Carrier) nc
Number of
extramedullary
hematopoietic
clusters
nc nc nc ↑ ↓ (UP) ↓ (UP)
NTCP nc nc nc nc ↑ (Sterol + Carrier & UP) nc
BSEP nc nc nc nc nc ↑ (Sterol + Carrier, UP &UP + Sterol + Carrier)
tBAs plasma nc nc nc nc nc nc
tBAs liver nc nc nc nc nc nc
CYP7A1 nc nc nc nc nc nc
CYP27A1 nc nc nc nc nc nc
ASBT nc nc nc nc nc nc
OSTα-β nc nc nc nc nc nc
FGF19 nc nc nc nc nc nc
IBABP nc nc nc nc nc nc
nc: Not changed. ↑ or ↓: Increased or decreased compared to control. ↑ or ↓ (group): Increased or decreased
compared to the mentioned group(s).
4. Discussion
Chorioamnionitis induced by IA UP exposure for six days caused an inflammatory reaction in the
liver, characterized by increased sinusoidal dilation and an increased number of extramedullary
hematopoietic clusters. Specifically, clustering and conflation of hepatic erythropoiesis in the
parenchyma were observed in these animals. This phenomenon was also observed in human
babies born stillborn, in whom there was an increase in total hematopoiesis and erythropoiesis
with clustering of erythropoietic cells, which was strongly associated with chorioamnionitis [29],
implicating that antenatal inflammation alters fetal extramedullary hematopoiesis. The observed
fetal hepatic cellular response to chorioamnionitis in our study might be the result of the fetal
systemic inflammatory response (FIRS; increased circulatory IL-6 levels [16]), or direct exposure to
inflammatory mediators through the transport from the gut via the portal vein, or a combination of
both. Additionally, the distribution of erythropoiesis was altered in the previously mentioned study
in humans, in which erythropoietic activity was often expanded over the whole portal field and the
sinusoids in the case of chorioamnionitis [29]. However, in our study, we observed alterations of fetal
intrahepatic erythropoiesis in the parenchyma. Whether this difference is species-dependent remains
to be elucidated, since no previous data on alterations of fetal intrahepatic erythropoiesis is present
in sheep.
In our study, prophylactic IA exposure to carrier or carrier enriched with plant sterols prior to IA
UP exposure partly decreased the number of clusters of erythropoiesis in the liver parenchyma. In our
study, the carrier β-cyclodextrin exerted similar anti-inflammatory effects in the liver as was previously
observed in the gut by plant sterols [16]. The effects in the gut were explained by the plant sterols and
the carrier β-cyclodextrin apparently having overlapping working mechanisms [16]. Given the fact
that plant sterols dissolved in the carrier, and the carrier alone possessed similar anti-inflammatory
effects, our data suggests that the anti-inflammatory effects in the liver might be solely the result of the
carrier β-cyclodextrin.
Caution to use plant sterols in the fetal setting of chorioamnionitis might be required, since
sterol-treated animals displayed enlarged central veins in combination with pronounced sinusoidal
dilatation, implying hepatic congestion [30]. However, not significant in the case of carrier
administration alone, these effects were also visible elsewhere, concluding that one should be cautious
here as well.
A previous study in the same model showed that chorioamnionitis induced by six days of IA UP
exposure caused a reduction of conjugated BAs in the enterocytes of the terminal ileum of fetal sheep in
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the same model [16]. This might indicate that, as a result of chorioamnionitis, the uptake of BAs from
the lumen into the enterocyte is reduced, or the amount of BAs in the lumen is reduced by a potential
decreased excretion of BAs from the liver into the intestine, or a reduced BA synthesis. However, in
our study, none of the above could explain the reduction of conjugated BAs in the enterocytes of the
terminal ileum, since mRNA expression levels of the BA transporter responsible for the uptake of
conjugated BAs in the terminal ileum, ASBT, were unchanged in animals exposed to UP. Moreover,
mRNA expression levels of the pump responsible for the excretion of BAs from the hepatocytes into
the bile canaliculi, BSEP, remained unaltered in animals exposed to UP alone.
Our findings suggest that the BAs synthesis in the liver of UP-exposed animals remained
unchanged. This is an interesting finding since we previously demonstrated in these animals a
reduction of conjugated BAs in enterocytes, and reduced fetal circulatory lathosterol concentrations,
indicative of a reduced (hepatic) endogenous cholesterol synthesis [16]. Since BAs are synthesized
via oxidation of cholesterol [31], we assumed we would detect an altered syntheses of primary BAs
as a result of IA UP exposure. However, the liver cholesterol pool was sufficient to such an extent
that it did not have a negative impact on the syntheses of primary BAs. It might be possible that the
conjugated BAs that were not absorbed in the terminal ileum of the fetal sheep via the ASBT were
deconjugated in the colon and subsequently passively absorbed. When the deconjugated BAs would
not have been passively absorbed in the colon, they would be lost in the feces. In this case, one would
have expected increased BAs syntheses to maintain a constant BA pool, suggesting that there was no
loss of BAs in our study.
In our study, we could not observe the EHC alterations found in experimental NEC and neonates
with NEC. A possible explanation for this discrepancy could be that the EHC alterations contributing
to NEC pathology do not have their origin in utero but might manifest after birth.
Finally, sterols dissolved in the carrier or carrier alone did not cause any alterations in the EHC.
However, in combination with UP, increased mRNA expression levels of NTCP and BSEP were found.
Although exposure to plant sterols dissolved in the carrier as well as the β-cyclodextrin carrier alone
prior to UP caused changes in the expression of several hepatic BAs transporters, this did not cause
EHC alterations further up in the circulation, e.g., altered BAs synthesis or altered ASBT mRNA
expression levels, suggesting that these alterations might not be biologically relevant.
Overall, we can conclude from this study that the observed effects are not the result of the addition
of plant sterols to the carrier β-cyclodextrin but can be fully assigned to the carrier β-cyclodextrin
alone. We have previously found that plant sterols and the carrier β-cyclodextrin protect the fetal gut
against chorioamnionitis induced gut inflammation and injury [16]. Based on these earlier findings
and the current study, we conclude that β-cyclodextrin is an interesting pharmaceutical target to
protect the gut and liver against the negative consequences of perinatal inflammatory stress [32,33].
Importantly, cyclodextrins are highly water-soluble, “ready-made,” and commercially available. Its
pharmacokinetics and the optimal moment and route of administration in the fetal or neonatal context
warrant further investigation.
In summary, IA UP exposure caused an inflammatory reaction in the liver, which was partially
prevented by IA β-cyclodextrin administration. In addition, IA administration of β-cyclodextrin prior
to UP caused changes in the expression of several hepatic BAs transporters, without causing alterations
in other aspects of the EHC. Thereby, the addition of plant sterols to the carrier β-cyclodextrin did not
have additional effects.
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ASBT Apical sodium–dependent bile acid transporter
AU Arbitrary unit
BAs Bile acids
BSEP Bile salt export pump
CCU Color-changing units
CYP7A1 Cholesterol 7 alpha-hydroxylase
CYP27A1 Cytochrome P450 Family 27 Subfamily A Member 1
EHC Enterohepatic circulation
FGF19 Fibroblast growth factor 19
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
IA Intra-amniotic
IBABP Ileal bile acid-binding protein
IQR Interquartile range
NEC Necrotizing enterocolitis
NTCP Na+-taurocholate cotransporting polypeptide
OSTα Organic solute transporter alpha
OSTβ Organic solute transporter bèta
PPIA Peptidylprolyl isomerase A
RPS15 Ribosomal protein S15
tBAs Total bile acids
UP Ureaplasma parvum
qPCR Quantitative real-time PCR
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